InvestorsHub Logo
icon url

david02835

04/12/06 7:15 AM

#32839 RE: downregul8 #32834

Downregul8, Thank you for your very helpful thoughts. You sound as if you put a lot of DD into this stock. I have a much better feel for a practical time line for CYGX as an investment. Your observations of past performance and projections for the future here mirror another pharma stock I have been involved in, DDD, which doesn't have as exciting products as CYGX but has been experiencing the rate of growth that you describe. I hope others read your post. Thanks.
icon url

neo43

04/12/06 8:57 PM

#32907 RE: downregul8 #32834

dowregul8, re one of your points . ..

in the post I'm replying to. You may want to reconsider one of your assumptions, viz., "The completion/certification of the cGMP facility has not been announced yet, which limits the short-term sales to pre-clinical trails – and more importantly pre-clinical amounts - sub gram quantities."

You must not have noticed my post last Friday: http://www.investorshub.com/boards/read_msg.asp?message_id=10586070

The relevant sentence: "the FDA isn't requiring DNA used in pre-clinical testing or Phase I trials to conform to . . . cGMP rules."

This came from someone who definitely should know.